Quidel Corp. Company Profile (NASDAQ:QDEL)

Analyst Ratings

Consensus Ratings for Quidel Corp. (NASDAQ:QDEL) (?)
Ratings Breakdown: 3 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $19.90 (1.84% upside)

Analysts' Ratings History for Quidel Corp. (NASDAQ:QDEL)
Show:
DateFirmActionRatingPrice TargetActions
6/13/2016Raymond James Financial Inc.UpgradeMarket Perform -> Outperform$21.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2016Craig HallumLower Price TargetHold$18.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2016Barclays PLCLower Price TargetOverweight$28.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2016Piper Jaffray Cos.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2016William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2014JPMorgan Chase & Co.Reiterated RatingNeutral$21.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2014WedbushUpgradeUnderperform -> Neutral$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Quidel Corp. (NASDAQ:QDEL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/27/2016Q216($0.25)$37.98 millionListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2016Q116($0.07)$0.02$49.21 million$50.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2016Q415$0.05$0.10$54.01 million$52.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q315($0.14)$0.05$43.48 million$46.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/22/2015Q215($0.25)($0.14)$34.17 million$34.87 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q115$0.12$0.30$61.22 million$61.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2015Q414$0.10$0.37$60.61 million$63.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/21/2014Q314($0.12)($0.01)$37.80 million$40.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/22/2014Q214($0.16)($0.10)$31.90 million$31.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2014Q114$0.30$0.08$63.26 million$46.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2014Q413$0.09$0.20$48.67 million$50.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013Q313($0.07)($0.02)$37.32 million$33.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013($0.11)($0.06)$33.24 million$29.71 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2013Q1 2013$0.46$0.49$62.63 million$61.99 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2013Q4 2012$0.29$0.26$53.30 million$53.93 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2012($0.03)$0.08ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2012($0.08)$0.01ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2012$0.06$0.15ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011($0.06)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011($0.07)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$0.33$0.35ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2011($0.01)$0.02ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Quidel Corp. (NASDAQ:QDEL)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.17)$0.21$0.02
Q2 20162($0.27)($0.21)($0.24)
Q3 20162($0.04)($0.02)($0.03)
Q4 20161$0.22$0.22$0.22
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Quidel Corp. (NASDAQ:QDEL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Quidel Corp. (NASDAQ:QDEL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/19/2016Douglas C. BryantCEOBuy3,700$13.91$51,467.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2015John TameriusSVPSell21,109$21.95$463,342.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015Douglas C BryantCEOBuy20,000$19.76$395,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014John TameriusSVPSell5,000$28.00$140,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2014John TameriusSVPSell10,000$26.50$265,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2014Douglas C BryantCEOBuy20,000$24.12$482,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2014John TameriusSVPSell15,000$24.50$367,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2014John TameriusSVPSell5,000$23.06$115,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2014John TameriusSVPSell47,246$27.69$1,308,241.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2014Rodney DammeyerDirectorSell26,000$27.70$720,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Mark PulidoDirectorSell12,750$25.31$322,702.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2013Robert Joseph BujarskiSVPSell28,808$23.16$667,193.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013Robert Joseph BujarskiSVPSell27,479$23.12$635,314.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Quidel Corp. (NASDAQ:QDEL)
DateHeadline
07/21/16 08:51 AMQuidel Corporation (QDEL) is Trading Lower on Unusual Volume for July 19
07/18/16 08:30 AMZacks.com featured highlights: Lancaster Colony, Quidel, Klondex Mines, Honeywell International and Global Brass and Copper Holdings -
07/14/16 06:16 PMQuidel Corporation: Quidel to Hold Second Quarter 2016 Financial Results ...
07/14/16 05:52 AMQuidel (QDEL) Shares March Higher, Can It Continue? -
07/13/16 02:38 PMGenome Web: Quidel’s Solana Group A Strep Test Fares Well in Prospective Evaluation - [at noodls] - 22417305-4f67-4255-8bc2-ba301159fc67.pdf Quidel's Solana Group A Strep Test Fares Well in Prospective Evaluation Jul 12, 2016 | Madeleine Johnson NEW YORK (GenomeWeb) - A Group A Strep test to rapidly ...
07/13/16 02:38 PMQuidel to Hold Second Quarter 2016 Financial Results Conference Call on July 27, 2016 - [at noodls] - SAN DIEGO, CA -- (Marketwired) -- 07/13/16 -- Quidel Corporation(NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report ...
06/27/16 09:11 AMQuidel Corp. breached its 50 day moving average in a Bearish Manner : QDEL-US : June 27, 2016 -
06/13/16 07:41 AMQuidel Corp. breached its 50 day moving average in a Bearish Manner : QDEL-US : June 13, 2016 -
06/06/16 04:13 PMQuidel Corp. – Value Analysis (NASDAQ:QDEL) : June 6, 2016 -
06/03/16 07:12 AMQuidel Corp. breached its 50 day moving average in a Bullish Manner : QDEL-US : June 3, 2016 -
05/19/16 01:03 PMQUIDEL CORP /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/04/16 03:32 PMETF’s with exposure to Quidel Corp. : May 4, 2016 -
05/03/16 07:26 AMQuidel Corp. breached its 50 day moving average in a Bearish Manner : QDEL-US : May 3, 2016 -
05/02/16 12:32 PMQuidel Corp. :QDEL-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/29/16 12:15 PMQUIDEL CORP /DE/ Files SEC form 10-Q, Quarterly Report -
04/28/16 03:15 PMQuidel to Present at the Bank of America Merrill Lynch 2016 Health Care Conference - [at noodls] - SAN DIEGO, CA -- (Marketwired) -- 04/28/16 -- Quidel Corporation(NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
04/28/16 12:24 AMEdited Transcript of QDEL earnings conference call or presentation 27-Apr-16 9:00pm GMT -
04/27/16 05:31 PMQuidel reports 1Q loss -
04/27/16 03:40 PMQuidel Reports First Quarter 2016 Financial Results - [at noodls] - SAN DIEGO, CA -- (Marketwired) -- 04/27/16 -- Quidel Corporation(NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
03/14/16 07:18 AMQuidel Corp. breached its 50 day moving average in a Bullish Manner : QDEL-US : March 14, 2016 -
02/25/16 05:02 AMQUIDEL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers -
02/23/16 05:02 AMQUIDEL CORP /DE/ Files SEC form 10-K, Annual Report -
02/19/16 10:10 AMQuidel Corp. Earnings Analysis: 2015 By the Numbers -
02/17/16 11:08 PMEdited Transcript of QDEL earnings conference call or presentation 17-Feb-16 10:00pm GMT -
02/17/16 04:00 PMQuidel Corp Earnings Call scheduled for 5:00 pm ET today -
02/17/16 03:45 PMQuidel reports 4Q loss -
02/17/16 03:20 PMQUIDEL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
02/17/16 03:10 PMQuidel Reports Fourth Quarter and Full Year 2015 Financial Results - [Marketwired] - Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the fourth quarter and year ...
02/17/16 06:07 AMQ4 2015 Quidel Corp Earnings Release - After Market Close -
02/10/16 06:59 AMQuidel Slid 5% Following Canaccord Downgrade To Hold -
02/09/16 10:41 AMQuidel downgraded by Canaccord Genuity -
02/03/16 03:30 PMQuidel to Hold Fourth Quarter and Full Year 2015 Financial Results Conference Call on February 17, 2016 - [Marketwired] - Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fourth quarter and full year 2015 financial results ...
01/28/16 03:24 PMQUIDEL CORP /DE/ Files SEC form 8-K, Regulation FD Disclosure -
01/25/16 04:55 PMQuidel Receives CE Mark for Its New Sofia(R) Fluorescent Immunoassay for Diagnosis of Pneumococcal Pneumonia and Pneumococcal Meningitis - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received the CE Mark for Quidel's Sofia® S. pneumoniae Fluorescent Immunoassay (FIA) for use with the Sofia Fluorescent Immunoassay Analyzer. The Sofia S. pneumoniae FIA enables the rapid, qualitative detection of Streptococcus pneumoniae antigen in the urine of patients with pneumonia and in the cerebral spinal fluid (CSF) of patients with meningitis. Test results aid in the diagnosis of both pneumococcal pneumonia and pneumococcal meningitis. Streptococcus pneumoniae (SPN) is the leading cause of community-acquired pneumonia.1, 2 SPN can cause a wide spectrum of illnesses from upper respiratory tract infection to invasive pneumococcal disease. SPN infection is also associated with high mortality -- an estimated 1.6 million people die of pneumococcal diseases each year worldwide and approximately 1 million of these deaths are in ...Full story available on Benzinga.com
01/25/16 04:10 PM5:10 pm Quidel receives CE Mark for Quidel's Sofia pneumoniae Fluorescent Immunoassay for use with the Sofia Fluorescent Immunoassay Analyzer -
01/08/16 11:17 AMQUIDEL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financi -
01/07/16 05:52 PMQuidel Announces Preliminary Revenue for Fourth Quarter 2015 - [at noodls] - Quidel Announces Preliminary Revenue for Fourth Quarter 2015
01/05/16 07:44 AMQuidel Corp. breached its 50 day moving average in a Bearish Manner : January 5, 2016 -
12/21/15 08:14 AMQuidel Corp. breached its 50 day moving average in a Bearish Manner : December 21, 2015 -
12/17/15 07:38 AMCan Quidel Corp. (QDEL) Keep the Earnings Streak Alive This Quarter? -
12/14/15 12:15 PMQuidel Seen as Good Bet on Flu Season Drugs -
12/08/15 12:16 PMQUIDEL CORP /DE/ Financials -
11/27/15 04:46 PMBlackstone / GSO Strategic Credit Fund (BGB): Hedge Funds Are Snapping Up -
11/21/15 01:56 PMOsiris Therapeutics, Inc. (OSIR): Are Hedge Funds Right About This Stock? -
11/18/15 03:17 PMQUIDEL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -
11/17/15 04:09 PMCharlie Slacik Joins Quidel's Board of Directors - [at noodls] - SAN DIEGO, CA -- (Marketwired) -- 11/17/15 -- Quidel Corporation(NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
11/04/15 08:36 AMThree Stocks Witnessing Insider Buying; Twitter Inc. (TWTR) Among Them -
10/30/15 08:44 AMQuidel Corp. breached its 50 day moving average in a Bullish Manner : October 30, 2015 -

Social

About Quidel Corp.

Quidel Corp. logoQuidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company's diagnostic testing solutions primarily include applications in infectious diseases, women's health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers. It markets its products in the United States through a network of national and regional distributors and a direct sales force. Internationally, it sells and markets primarily through distributor arrangements. Its diagnostic solutions are used in the detection and diagnosis of many critical diseases and other medical conditions, including autoimmune diseases, bone health and thyroid diseases. It provides diagnostic testing solutions under various brand names, including Quidel, QuickVue+ and Thyretain.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: QDEL
  • CUSIP: 74838J10
Key Metrics:
  • Previous Close: $19.63
  • 50 Day Moving Average: $18.41
  • 200 Day Moving Average: $17.28
  • P/E Ratio: N/A
  • P/E Growth: -6.54
  • Market Cap: $631.77M
  • Beta: 0.73
  • Current Year EPS Consensus Estimate: $-0.16 EPS
  • Next Year EPS Consensus Estimate: $0.3 EPS
Additional Links:
Quidel Corp. (NASDAQ:QDEL) Chart for Saturday, July, 23, 2016